8-K: Varex Refinances Debt, Cuts Interest Costs by $7M Annually
Debt Refinancing Announcement
Varex Imaging Corporation successfully refinanced $368 million in senior secured notes with a new $490 million credit facility, expecting over $7 million in annual cash interest savings.
Summary
- Varex Imaging Corporation entered into a new Credit and Guaranty Agreement on March 13, 2026, establishing a $490 million Credit Facility.
- The new Credit Facility includes a $350 million secured term loan, a $100 million secured revolving credit facility (with a $35 million letter of credit subfacility and a $20 million swingline subfacility), and a $40 million secured delayed draw term loan facility.
- All facilities under the new Credit Agreement mature on March 13, 2031.
- Borrowings bear interest at a variable rate based on the Secured Overnight Financing Rate (SOFR) plus an applicable margin, initially 2.50% based on the company's consolidated total net leverage ratio.
- Varex drew down $350 million from the term loan facility on March 13, 2026, using the proceeds and cash on hand to redeem its $368 million aggregate principal amount of 7.875% Senior Secured Notes due 2027.
- The redemption of the 2027 Notes occurred on March 16, 2026, and the associated indenture was satisfied and discharged.
- The company also terminated its previous $155 million revolving credit facility, which had no outstanding borrowings at the time of termination.
- An interest rate swap was entered into, effectively converting the variable SOFR component to a fixed SOFR of 3.65%.
- The refinancing involved approximately $42 million in cash, comprising an $18 million net reduction in outstanding debt, a $7 million call premium, $12 million in accrued interest on the redeemed notes, and $5 million in transaction fees.
- The new revolving credit facility is available for working capital and general corporate purposes, while the delayed draw term loan is for capital expenditures.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a highly positive development. The successful debt refinancing significantly reduces interest expenses, improves financial flexibility, and extends debt maturities, all of which are strong indicators of prudent financial management and a strengthened balance sheet.
Positives
- The refinancing is expected to reduce annualized cash interest expense by more than $7 million.
- The transaction strengthens the company's balance sheet and improves its cost of capital.
- Reduced debt and lower interest rates are anticipated to improve financial flexibility and support enhanced free cash flow generation.
- The new credit facility provides a longer maturity profile, extending debt maturities to March 13, 2031.
Negatives
- The refinancing incurred approximately $42 million in cash expenses, including a $7 million call premium and $5 million in transaction fees.
- The company used $18 million of cash for a net reduction in outstanding debt, indicating a cash outflow for debt reduction.
Risks
- The need for greater borrowing under the Credit Facility than management's current expectations.
- Increases in the company's consolidated net leverage ratio could lead to higher interest rates.
- Early termination of the company's interest rate swap arrangement.
- Other factors that could cause interest rates to exceed current projections.
- General risks set forth in the company's Quarterly and Annual Reports filed with the SEC.
Future Outlook
The company expects the reduced debt and lower interest rates from the refinancing to improve financial flexibility, support improved free cash flow generation, and enable continued investment in its core business while prioritizing long-term shareholder value. The company also plans to use commercially reasonable efforts to enter into customary interest rate hedging for at least 50% of its term loans.
Management Comments
- "We are excited to have successfully closed the new credit agreement and redeemed our senior secured notes, strengthening our balance sheet and improving our cost of capital."
- "We expect that the reduced debt and lower interest rate will improve financial flexibility, support improved free cash flow generation and enable continued investment in our core business while prioritizing long-term shareholder value."
Industry Context
StockSavvy.ai notes that Varex Imaging's debt refinancing aligns with a broader trend among companies to optimize capital structures in response to evolving interest rate environments. By securing a new credit facility with a lower effective interest rate and extending maturities, Varex is positioning itself for enhanced financial stability and flexibility, which is crucial for capital-intensive industries like medical and industrial X-ray imaging components. This move could provide a competitive advantage by freeing up cash for R&D, strategic acquisitions, or other growth initiatives, similar to how other technology and manufacturing firms manage their debt to fuel innovation and market expansion.
Comparison to Industry Standards
- The new credit facility's maturity of March 13, 2031, provides a five-year term, which is a standard duration for corporate credit facilities, offering stability compared to shorter-term debt.
- The initial applicable margin of 2.50% over SOFR, combined with a fixed SOFR of 3.65% via swap, results in an effective interest rate that appears competitive given current market conditions and Varex's leverage profile, though specific comparable company rates are not provided in the filing.
- The reduction in annualized cash interest expense by over $7 million is a significant improvement, indicating a successful optimization of the capital structure, which is a key performance indicator for financial health in any industry.
- The Consolidated Total Net Leverage Ratio covenants, starting at 4.25:1.00 and stepping down to 3.75:1.00, are within typical ranges for companies of Varex's size and industry, allowing for operational flexibility while maintaining financial discipline.
- The Consolidated Fixed Charge Coverage Ratio minimum of 1.20:1.00 is a common benchmark for ensuring a company's ability to cover its debt obligations.
Stakeholder Impact
- Shareholders: Expected to benefit from improved financial flexibility, reduced interest expenses, and enhanced free cash flow generation, potentially leading to increased long-term shareholder value.
- Creditors (New Lenders): Will benefit from a secured position under the new Credit Facility and adherence to financial covenants.
- Old Noteholders: Received full redemption of their 7.875% Senior Secured Notes due 2027, including a call premium and accrued interest.
- Employees: Continued investment in the core business may support job stability and growth opportunities.
Next Steps
- The company will continue to invest in its core business.
- Prioritize long-term shareholder value.
- Use commercially reasonable efforts to enter into customary interest rate hedging for at least 50% of the aggregate principal amount of the Initial Term Loans and any Incremental Term Loans within 90 days of their respective funding dates, with a tenor not terminating prior to the fourth anniversary of the Closing Date.
Key Dates
| Date | Description |
|---|---|
| 2020-09-30 | Date of the Senior Secured Notes Indenture for the 7.875% Senior Secured Notes due 2027. |
| 2024-03-26 | Date of the previously existing Revolving Credit and Guaranty Agreement, which was terminated. |
| 2026-03-06 | Varex delivered a notice of conditional full redemption for its 2027 Notes. |
| 2026-03-13 | Date of earliest event reported; Varex Imaging Corporation and its subsidiaries entered into the new Credit and Guaranty Agreement. $350 million term loan facility was drawn down. Sufficient funds were irrevocably deposited with the trustee to redeem the 2027 Notes. The 2027 Notes Indenture was satisfied and discharged. The previous Revolving Credit and Guaranty Agreement was terminated. |
| 2026-03-16 | Redemption Date for the $368 million 7.875% Senior Secured Notes due 2027. Press release announcing the closing of the Credit Facility was issued. |
| 2027-03-13 | Start of the period where the maximum Consolidated Total Net Leverage Ratio is 4.25:1.00. |
| 2027-09-26 | Scheduled maturity date of the Terminated Credit Agreement. |
| 2027-12-01 | Start of the period where the maximum Consolidated Total Net Leverage Ratio is 4.00:1.00. |
| 2028-12-01 | Start of the period where the maximum Consolidated Total Net Leverage Ratio is 3.75:1.00. |
| 2031-03-13 | Maturity Date for all facilities under the new Credit Agreement. |
Recommendation
strong buyThe successful debt refinancing significantly reduces Varex Imaging's annual cash interest expense by over $7 million and extends its debt maturity profile, which are strong positive indicators for financial health and future profitability. This move enhances financial flexibility, supports free cash flow generation, and enables continued investment in the core business, all of which are favorable for long-term shareholder value. The immediate financial benefits and strengthened balance sheet make this a compelling 'strong buy' signal for investors.
Keywords
Varex Imaging, Debt Refinancing, Credit Facility, Term Loan, Revolving Credit, SOFR, Interest Rate Swap, SEC Filing, Financial Flexibility, Cost of Capital, Senior Secured Notes, Capital Expenditures
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.